Nitroglycerin In Dextrosenitroglycerin

According to the FDA label: INDICATIONS & USAGE Nitroglycerin in 5% Dextrose Injection is indicated for treatment of peri-operative hypertension; for control of heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and ß-blockers; and for induction of intraoperative hypotension.

39,095 adverse event reports submitted to the FDA (1999–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Nitroglycerin In Dextrose in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Nitroglycerin In Dextrose adverse event reports by reporter sex
SexReports
Male19,036
Female17,135
Unknown33

By Age Group

View age group data as a table
Nitroglycerin In Dextrose adverse event reports by reporter age group
Age groupReports
0-17185
18-34386
35-491,982
50-647,875
65-747,676
75+9,873

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Nitroglycerin In Dextrose. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Nitroglycerin In Dextrose adverse event reports by reported outcome
OutcomeReports
Other Serious20,371
Hospitalization18,692
Non-Serious7,153
Death5,272
Life-Threatening2,416
Disability1,298

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Nitroglycerin In Dextrose. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Nitroglycerin In Dextrose adverse event reports by year
YearReports
19991
20021
20032
2004948
20051,062
2006897
2007676
2008899
20091,199
20101,365
20112,237
20121,664
2013816
20142,367
20151,408
20161,613
20171,691
20182,070
20192,224
20202,076
20212,214
20222,849
20232,835
20242,787
20252,661
2026 (partial)533

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Nitroglycerin In Dextrose

In FDA adverse event reports that mention Nitroglycerin In Dextrose, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026